Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

296 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and efficacy of lenvatinib in elderly patients with unresectable hepatocellular carcinoma: A multicenter analysis with propensity score matching.
Tada T, Kumada T, Hiraoka A, Michitaka K, Atsukawa M, Hirooka M, Tsuji K, Ishikawa T, Takaguchi K, Kariyama K, Itobayashi E, Tajiri K, Shimada N, Shibata H, Ochi H, Toyoda H, Nouso K, Tsutsui A, Nagano T, Itokawa N, Hayama K, Imai M, Joko K, Koizumi Y, Hiasa Y. Tada T, et al. Among authors: nouso k. Hepatol Res. 2020 Jan;50(1):75-83. doi: 10.1111/hepr.13427. Epub 2019 Dec 6. Hepatol Res. 2020. PMID: 31660700
Hepatocellular carcinoma occurring in hepatobiliary fibropolycystic disease.
Kinugasa H, Nouso K, Kobayashi Y, Yasunaka T, Onishi H, Nakamura S, Shiraha H, Takayama H, Toshimori J, Kuwaki K, Hagihara H, Miyake Y, Ikeda F, Takaki A, Kobashi H, Yamamoto K. Kinugasa H, et al. Among authors: nouso k. Hepatol Res. 2011 Mar;41(3):277-81. doi: 10.1111/j.1872-034X.2010.00761.x. Hepatol Res. 2011. PMID: 21338456
Long-term outcome and hepatocellular carcinoma development in chronic hepatitis B or cirrhosis patients after nucleoside analog treatment with entecavir or lamivudine.
Kobashi H, Miyake Y, Ikeda F, Yasunaka T, Nishino K, Moriya A, Kubota J, Nakamura S, Takaki A, Nouso K, Yamada G, Yamamoto K. Kobashi H, et al. Among authors: nouso k. Hepatol Res. 2011 May;41(5):405-16. doi: 10.1111/j.1872-034X.2011.00785.x. Epub 2011 Mar 21. Hepatol Res. 2011. PMID: 21435126
Fulminant hepatitis: Who survives without liver transplantation?
Miyake Y, Yasunaka T, Ikeda F, Takaki A, Nouso K, Yamamoto K. Miyake Y, et al. Among authors: nouso k. Hepatol Res. 2012 Jan;42(1):60-7. doi: 10.1111/j.1872-034X.2011.00894.x. Epub 2011 Oct 11. Hepatol Res. 2012. PMID: 21988414
Cost-effectiveness analysis on the surveillance for hepatocellular carcinoma in liver cirrhosis patients using contrast-enhanced ultrasonography.
Tanaka H, Iijima H, Nouso K, Aoki N, Iwai T, Takashima T, Sakai Y, Aizawa N, Iwata K, Ikeda N, Iwata Y, Enomoto H, Saito M, Imanishi H, Nishiguchi S. Tanaka H, et al. Among authors: nouso k. Hepatol Res. 2012 Apr;42(4):376-84. doi: 10.1111/j.1872-034X.2011.00936.x. Epub 2012 Jan 3. Hepatol Res. 2012. PMID: 22221694
296 results